Skip to main content
  • FDA Gives Nod to Medtronic Drug-Coated Balloon The IN.PACT Admiral now heads to stented arteries

    The FDA gave Medtronic a green light to market the IN.PACT Admiral drug-coated balloon in the U.S. for cases of in-stent restenosis in patients with peripheral artery disease.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details